craft-sa-dev Home  

PMC:138691 / 6742-6923 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1609 0-181 sentence denotes Conversely, the BRCA2 defect in CAPAN-1 could be fully responsible for the 100-fold defect in recombination if the level of BRCA2 complementation observed by Powell was incomplete.
T1610 1-11 RB denotes Conversely
T1612 11-13 , denotes ,
T1613 13-16 DT denotes the
T1615 17-22 NN denotes BRCA2
T1614 23-29 NN denotes defect
T1616 30-32 IN denotes in
T1617 33-38 NN denotes CAPAN
T1618 38-39 HYPH denotes -
T1619 39-40 CD denotes 1
T1620 41-46 MD denotes could
T1611 47-49 VB denotes be
T1621 50-55 RB denotes fully
T1622 56-67 JJ denotes responsible
T1623 68-71 IN denotes for
T1624 72-75 DT denotes the
T1626 76-84 JJ denotes 100-fold
T1625 85-91 NN denotes defect
T1627 92-94 IN denotes in
T1628 95-108 NN denotes recombination
T1629 109-111 IN denotes if
T1631 112-115 DT denotes the
T1632 116-121 NN denotes level
T1633 122-124 IN denotes of
T1634 125-130 NN denotes BRCA2
T1635 131-146 NN denotes complementation
T1636 147-155 VBN denotes observed
T1637 156-158 IN denotes by
T1638 159-165 NNP denotes Powell
T1630 166-169 VBD denotes was
T1639 170-180 JJ denotes incomplete
T1640 180-181 . denotes .
R1136 T1610 T1611 advmod Conversely,be
R1137 T1612 T1611 punct ", ",be
R1138 T1613 T1614 det the,defect
R1139 T1614 T1611 nsubj defect,be
R1140 T1615 T1614 compound BRCA2,defect
R1141 T1616 T1614 prep in,defect
R1142 T1617 T1616 pobj CAPAN,in
R1143 T1618 T1617 punct -,CAPAN
R1144 T1619 T1617 nummod 1,CAPAN
R1145 T1621 T1622 advmod fully,responsible
R1146 T1622 T1611 acomp responsible,be
R1147 T1623 T1622 prep for,responsible
R1148 T1624 T1625 det the,defect
R1149 T1625 T1623 pobj defect,for
R1150 T1620 T1611 aux could,be
R1151 T1627 T1625 prep in,defect
R1152 T1628 T1627 pobj recombination,in
R1153 T1626 T1625 amod 100-fold,defect
R1154 T1630 T1611 advcl was,be
R1155 T1631 T1632 det the,level
R1156 T1629 T1630 mark if,was
R1157 T1633 T1632 prep of,level
R1158 T1634 T1635 compound BRCA2,complementation
R1159 T1632 T1630 nsubj level,was
R1160 T1636 T1632 acl observed,level
R1161 T1637 T1636 agent by,observed
R1162 T1638 T1637 pobj Powell,by
R1163 T1639 T1630 acomp incomplete,was
R1164 T1635 T1633 pobj complementation,of
R1166 T1640 T1611 punct .,be